US Stock MarketDetailed Quotes
NRBO NeuroBo Pharmaceuticals
- 3.4400
- -0.0200-0.58%
Close Apr 18 16:00 ET
- 3.4500
- +0.0100+0.29%
Post 18:24 ET
16.88MMarket Cap-1398P/E (TTM)
3.5900High3.3534Low22.79KVolume3.5900Open3.4600Pre Close78.36KTurnover0.48%Turnover RatioLossP/E (Static)4.91MShares6.749952wk High1.01P/B16.22MFloat Cap2.888852wk Low--Dividend TTM4.71MShs Float129539.9482Historical High--Div YieldTTM6.84%Amplitude2.8880Historical Low3.4380Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
NeuroBo Pharmaceuticals Stock Forum
Leading Medical Company Receives FDA Clearance For Obesity Drug Candidate
In a significant milestone for obesity treatment, NeuroBo Pharmaceuticals, a leading pharmaceutical company, has received FDA clearance to commence a Phase 1 clinical trial for its new drug candidate, DA-1726. This marks a critical advancement in the medical field, with potential far-reaching implicati...
News another weight loss drug! Hehehe
Movement with news... recent RS
$NeuroBo Pharmaceuticals(NRBO.US)$
to wake up to this and then realize I can't sell any..smfh
if any of you have been my follower since ytd you will realize this stock trend is kinda similar to $Aehr Test Systems(AEHR.US)$ during pre market
No comment yet